• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多重减毒慢病毒载体在体内实现高效基因递送。

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.

作者信息

Zufferey R, Nagy D, Mandel R J, Naldini L, Trono D

机构信息

Salk Institute, La Jolla, CA 92037-1099, USA.

出版信息

Nat Biotechnol. 1997 Sep;15(9):871-5. doi: 10.1038/nbt0997-871.

DOI:10.1038/nbt0997-871
PMID:9306402
Abstract

Retroviral vectors derived from lentiviruses such as HIV-1 are promising tools for human gene therapy because they mediate the in vivo delivery and long-term expression of transgenes in nondividing tissues. We describe an HIV vector system in which the virulence genes env, vif, vpr, vpu, and nef have been deleted. This multiply attenuated vector conserved the ability to transduce growth-arrested cells and monocyte-derived macrophages in culture, and could efficiently deliver genes in vivo into adult neurons. These data demonstrate the potential of lentiviral vectors in human gene therapy.

摘要

源自诸如HIV-1等慢病毒的逆转录病毒载体是人类基因治疗的有前景的工具,因为它们介导转基因在非分裂组织中的体内递送和长期表达。我们描述了一种HIV载体系统,其中毒力基因env、vif、vpr、vpu和nef已被删除。这种多重减毒载体保留了在培养中转导生长停滞细胞和单核细胞衍生巨噬细胞的能力,并且能够在体内有效地将基因递送至成年神经元。这些数据证明了慢病毒载体在人类基因治疗中的潜力。

相似文献

1
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo.多重减毒慢病毒载体在体内实现高效基因递送。
Nat Biotechnol. 1997 Sep;15(9):871-5. doi: 10.1038/nbt0997-871.
2
An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.一种用于在无HIV-1辅助蛋白情况下安全、高效生产慢病毒载体的可诱导包装细胞系统。
Virology. 2001 Mar 30;282(1):77-86. doi: 10.1006/viro.2000.0787.
3
Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.一种重组1型人类免疫缺陷病毒衍生载体系统的疗效与安全性分析。
Gene Ther. 1999 May;6(5):715-28. doi: 10.1038/sj.gt.3300895.
4
Hepatocyte-specific gene expression from integrated lentiviral vectors.整合慢病毒载体介导的肝细胞特异性基因表达。
J Gene Med. 2004 Sep;6(9):974-83. doi: 10.1002/jgm.591.
5
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.通过慢病毒载体直接导入肝脏和肌肉的基因的持续表达。
Nat Genet. 1997 Nov;17(3):314-7. doi: 10.1038/ng1197-314.
6
A stable system for the high-titer production of multiply attenuated lentiviral vectors.一种用于高滴度生产多重减毒慢病毒载体的稳定系统。
Mol Ther. 2000 Aug;2(2):170-6. doi: 10.1006/mthe.2000.0103.
7
Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.通过新型腺病毒/逆转录病毒嵌合载体实现体内稳定的基因转导。
Nat Biotechnol. 1997 Sep;15(9):866-70. doi: 10.1038/nbt0997-866.
8
Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.多重减毒、自我失活的慢病毒载体可在体外有效转导人冠状动脉细胞,并在体内转导大鼠动脉。
J Mol Cell Cardiol. 2005 Feb;38(2):333-44. doi: 10.1016/j.yjmcc.2004.11.031. Epub 2005 Jan 27.
9
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.用于在体外和体内将基因传递到新生和成年心室心肌细胞的慢病毒载体。
Basic Res Cardiol. 2002 Sep;97(5):348-58. doi: 10.1007/s00395-002-0360-0.
10
Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.靶向人类免疫缺陷病毒1型多个高度保守RNA序列的慢病毒小干扰RNA
Gene Ther. 2005 Jul;12(14):1133-44. doi: 10.1038/sj.gt.3302509.

引用本文的文献

1
Modeling Genetic Risk of β-Cell Dysfunction in Human Induced Pluripotent Stem Cells From Patients Carrying the MTNR1B Risk Variant.对携带MTNR1B风险变异的患者来源的人诱导多能干细胞中β细胞功能障碍的遗传风险进行建模。
J Pineal Res. 2025 Sep;77(5):e70073. doi: 10.1111/jpi.70073.
2
The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping.基因治疗时代:慢病毒载体及其假型化的进展
Viruses. 2025 Jul 24;17(8):1036. doi: 10.3390/v17081036.
3
Pseudovirus as an Emerging Reference Material in Molecular Diagnostics: Advancement and Perspective.
假病毒作为分子诊断中新兴的参考物质:进展与展望
Curr Issues Mol Biol. 2025 Jul 29;47(8):596. doi: 10.3390/cimb47080596.
4
Alpha-lipoic acid supplementation improves pathological alterations in cellular models of Friedreich ataxia.补充α-硫辛酸可改善弗里德赖希共济失调细胞模型中的病理改变。
Orphanet J Rare Dis. 2025 Aug 23;20(1):453. doi: 10.1186/s13023-025-03990-z.
5
Biosafety considerations triggered by genome-editing technologies.基因组编辑技术引发的生物安全考量。
Biosaf Health. 2025 May 13;7(3):141-151. doi: 10.1016/j.bsheal.2025.05.003. eCollection 2025 Jun.
6
Application Advances of Lentiviral Vectors: From Gene Therapy to Vaccine Development.慢病毒载体的应用进展:从基因治疗到疫苗开发
Mol Biotechnol. 2025 Jul 5. doi: 10.1007/s12033-025-01472-y.
7
Progress in Pseudotyping Lentiviral Vectors Towards Cell-Specific Gene Delivery In Vivo.慢病毒载体假型化用于体内细胞特异性基因递送的研究进展
Viruses. 2025 May 31;17(6):802. doi: 10.3390/v17060802.
8
Mitochondrial Unfolded Protein Response (mtUPR) Activation Improves Pathological Alterations in Cellular Models of Ethylmalonic Encephalopathy.线粒体未折叠蛋白反应(mtUPR)激活改善乙基丙二酸脑病细胞模型中的病理改变。
Antioxidants (Basel). 2025 Jun 16;14(6):741. doi: 10.3390/antiox14060741.
9
Three-dimensional cell-cell interactions promote direct reprogramming of patient fibroblasts into functional and transplantable neurons.三维细胞间相互作用促进患者成纤维细胞直接重编程为功能性且可移植的神经元。
Sci Adv. 2025 Jun 6;11(23):eadq7855. doi: 10.1126/sciadv.adq7855.
10
PDGFRα/β heterodimer activation negatively affects downstream ERK1/2 signaling and cellular proliferation.血小板衍生生长因子受体α/β异二聚体激活对下游细胞外信号调节激酶1/2信号传导和细胞增殖产生负面影响。
Nat Commun. 2025 May 22;16(1):4754. doi: 10.1038/s41467-025-59938-1.